Recall

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance

Recall from a federal regulator

Headline as published by U.S. Food and Drug Administration (MedWatch) on Nov 20, 2026; collected by the wire Nov 20, 2026, 7:00 PM ET.

Read at U.S. Food and Drug Administration (MedWatch)

FOR IMMEDIATE RELEASE - Tomball, Texas – November 20, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of compounded sterile products that remain within their beyond-use dates to the consumer level, including some products that were compounded by Greenwich Rx

From U.S. Food and Drug Administration (MedWatch)’s feed

Coverage

  1. U.S. Food and Drug Administration (MedWatch) Federal regulators

    Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Sterile Products Due to Lack of Sterility Assurance

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method